about
No effect of folic acid supplementation on global DNA methylation in men and women with moderately elevated homocysteineNo Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival.Dietary Supplement Use and Colorectal Adenoma Risk in Individuals with Lynch Syndrome: The GEOLynch Cohort Study.A comparative study on the WCRF International/University of Bristol methodology for systematic reviews of mechanisms underpinning exposure-cancer associations.Genistein and enterolactone in relation to Ki-67 expression and HER2 status in postmenopausal breast cancer patients.DNA methyltransferase and alcohol dehydrogenase: gene-nutrient interactions in relation to risk of colorectal polyps.The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity.Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study.MyD88 and TLR4 Expression in Epithelial Ovarian Cancer.Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium studyVariants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibilityA transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancerDietary B vitamin and methionine intake and MTHFR C677T genotype on risk of colorectal tumors in Lynch syndrome: the GEOLynch cohort studyPolygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer SubtypesPlasma B vitamins and LINE-1 DNA methylation in leukocytes of patients with a history of colorectal adenomasValidation of inflammatory genetic variants associated with long-term cancer related fatigue in a large breast cancer cohortCirculating enterolactone concentrations and prognosis of postmenopausal breast cancer: assessment of mediation by inflammatory markersPrognostic associations of circulating phytoestrogens and biomarker changes in long-term survivors of postmenopausal breast cancerPre- to postdiagnosis leisure-time physical activity and prognosis in postmenopausal breast cancer survivorsAntioxidant supplementation and breast cancer prognosis in postmenopausal women undergoing chemotherapy and radiation therapy
P50
Q28744606-57C55CEC-30D1-49FB-B61D-0E69EE62E1D4Q30275832-F47E1CA9-E54D-4C67-8863-7CA815075D77Q34794283-D9ADAE0B-C93C-4C6C-8547-C2B2C4DCE866Q38650111-2EB275EE-3CED-4978-AA4D-3834A3182AA7Q38666974-5125C718-3D26-46EB-B253-4167B0B4CAB6Q46758961-89F628F3-D1A9-4D2C-946D-EE759A058527Q49817640-44D72B91-3DCE-4040-8EA2-3BFB90E7A644Q52647897-2F6379EA-29D2-4EE2-984E-57221B4F8F26Q52675313-FF3A1B2C-0032-43BF-A8FF-72BB9FF38083Q56337548-0BC7D51B-63E6-4ED8-8A61-C762E0552B3CQ56342454-89487DD2-F074-4A3A-B67B-0A31D5742A19Q57305942-6AA06628-65FD-4896-8244-A1968F7BD8DDQ61542433-3C53E5A7-27C3-45F5-A7CF-9F801A7774CFQ62583133-9ACFB03E-43A6-49C8-91AF-A4B7A2C6638AQ85378974-9FE6C596-8BB3-4F88-80BF-AE98EF56D6CEQ88680084-BA71EF13-F53C-4DB6-9B5C-33408FB54650Q89425855-BD5687C0-341E-4E1F-A120-5C7565C479F2Q90742056-8CB2D90C-DA27-472B-928F-454F964D5CD1Q91149711-D1BD318C-0DF8-4110-8B27-65B00DED163EQ91159813-AAD8C79E-DCFF-4637-AA1C-4F9F6E8788ED
P50
description
researcher ORCID ID = 0000-0003-0875-6673
@en
wetenschapper
@nl
name
Audrey Y Jung
@ast
Audrey Y Jung
@en
Audrey Y Jung
@es
Audrey Y Jung
@nl
type
label
Audrey Y Jung
@ast
Audrey Y Jung
@en
Audrey Y Jung
@es
Audrey Y Jung
@nl
altLabel
Audrey Jung
@en
prefLabel
Audrey Y Jung
@ast
Audrey Y Jung
@en
Audrey Y Jung
@es
Audrey Y Jung
@nl
P106
P1153
57193520741
P31
P496
0000-0003-0875-6673